Page last updated: 2024-09-04

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and qx-314

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with qx-314 in 1 studies

Compound Research Comparison

Studies
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Trials
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Recent Studies (post-2010)
((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)
Studies
(qx-314)
Trials
(qx-314)
Recent Studies (post-2010) (qx-314)
85065297075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Y; Yu, S; Yu, X1

Other Studies

1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and qx-314

ArticleYear
QX-314 inhibits acid-induced activation of esophageal nociceptive C fiber neurons.
    Neurogastroenterology and motility, 2019, Volume: 31, Issue:4

    Topics: Acrylamides; Action Potentials; Animals; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Esophagus; Guinea Pigs; Hydrochloric Acid; Lidocaine; Nerve Fibers, Unmyelinated; Nociception; Patch-Clamp Techniques; TRPV Cation Channels

2019